SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.18-1.4%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Machaon who wrote (12811)12/23/1997 2:39:00 PM
From: David Bogdanoff  Read Replies (1) of 32384
 
To all;

Why are biotechs falling seems to be the current theme on this thread.
I will add my inflation devalued 2 cents worth. The general high market value makes people generally nervous and prone to sell perceived weaker stocks on the slightest bad news, nomatter how unrelated. The Asian crises certainly falls into this category of bad
news, even though it is unrelated to business prospects for the biotechs. The biotechs would generally be perceived as weak or speculative because most of them are months or years away before marketing their first product, and their products are not typically well understod (i.e they are not soft drinks). The timing of the Asian crises playes right into the hands of the tax loss sellers at the end of the year. It seems to me that these are enough reasons for the current biotech selloff even though their business prospects have not been adversely effected by the above mentioned circumstances. In fact, as has been mentioned on this thread, the low interest rates favor their prospects, plus recent government FDA regulation changes substantially favor these prospects since they should be able to get products to market faster and with less expense.

Just my opinion.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext